Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,822 | -3,807 | -15,424 | -11,421 | -7,498 |
| Depreciation Amortization | 1 | 1 | 1 | 1 | 1 |
| Other Working Capital | -151 | -905 | -518 | -1,173 | -737 |
| Other Operating Activity | 1,558 | 775 | 2,535 | 1,789 | 1,165 |
| Operating Cash Flow | $-6,414 | $-3,937 | $-13,405 | $-10,803 | $-7,069 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 17,141 | 17,141 | 10,141 |
| Investing Cash Flow | $N/A | $N/A | $17,141 | $17,141 | $10,141 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 376 | 336 | N/A | N/A | N/A |
| Other Financing Activity | -22 | -20 | 0 | 0 | 0 |
| Financing Cash Flow | $354 | $316 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 13,362 | 13,362 | 9,627 | 9,627 | 9,627 |
| End Cash Position | 7,302 | 9,742 | 13,362 | 15,964 | 12,698 |
| Net Cash Flow | $-6,060 | $-3,620 | $3,735 | $6,337 | $3,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,414 | -3,937 | -13,405 | -10,803 | -7,069 |
| Free Cash Flow | -6,414 | -3,937 | -13,405 | -10,803 | -7,069 |